CAS 190448-57-8
:Ezetimibe glucuronide
Description:
Ezetimibe glucuronide is a metabolite of the cholesterol absorption inhibitor ezetimibe, primarily formed through the process of glucuronidation in the liver. This compound is characterized by its role in enhancing the pharmacological effects of ezetimibe by increasing its solubility and facilitating its excretion. Ezetimibe itself works by selectively inhibiting the intestinal absorption of cholesterol, thereby lowering serum cholesterol levels. The glucuronide form is typically more polar, which can influence its bioavailability and pharmacokinetics. In terms of chemical structure, ezetimibe glucuronide features a glucuronic acid moiety linked to the ezetimibe molecule, which alters its interaction with biological systems. This modification can affect its efficacy and safety profile, making it an important consideration in pharmacotherapy for hyperlipidemia. The compound is generally studied in the context of drug metabolism and pharmacodynamics, contributing to a better understanding of how ezetimibe functions in the body and its potential therapeutic benefits.
Formula:C30H29F2NO9
InChI:InChI=1S/C30H29F2NO9/c31-17-5-1-15(2-6-17)22(34)14-13-21-23(33(28(21)38)19-9-7-18(32)8-10-19)16-3-11-20(12-4-16)41-30-26(37)24(35)25(36)27(42-30)29(39)40/h1-12,21-27,30,34-37H,13-14H2,(H,39,40)/t21-,22+,23-,24+,25+,26-,27+,30-/m1/s1
InChI key:InChIKey=UOFYCFMTERCNEW-ADEYADIWSA-N
SMILES:C(C[C@H](O)C1=CC=C(F)C=C1)[C@@H]2[C@H](N(C2=O)C3=CC=C(F)C=C3)C4=CC=C(O[C@@H]5O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]5O)C=C4
Synonyms:- 4-[(2S,3R)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl β-<span class="text-smallcaps">D</span>-glucopyranosiduronic acid
- 4-[(2S,3R)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl-D-Glucopyranosiduronic Acid
- Ezetimibe -D-Glucuronide, >85%
- Ezetimibe B-D-Glucuronide
- Ezetimibe glucuronide
- Ezm-G
- Sch 58235 Glucuronide
- Sch 60663
- β-<span class="text-smallcaps">D</span>-Glucopyranosiduronic acid, 4-[(2S,3R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl
- β-D-Glucopyranosiduronic acid, 4-[(2S,3R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl
- 4-[(2S,3R)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl β-D-glucopyranosiduronic acid
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
Ezetimibe glucuronide
CAS:Formula:C30H29F2NO9Purity:98%Color and Shape:SolidMolecular weight:585.5494Ezetimibe Phenoxy Glucuronide-d4
CAS:Formula:C30H25D4F2NO9Color and Shape:White To Off-White SolidMolecular weight:589.58Ezetimibe Phenoxy Glucuronide
CAS:Formula:C30H29F2NO9Color and Shape:White To Off-White SolidMolecular weight:585.56Ezetimibe phenoxy glucuronide
CAS:Ezetimibe phenoxy glucuronide (Ezetimibe glucuronide) is the active metabolite of Ezetimibe. Antihyperlipoproteinemic activity.Formula:C30H29F2NO9Purity:98%Color and Shape:SolidMolecular weight:585.55Ezetimibe phenoxy-β-D-glucuronide
CAS:Ezetimibe phenoxy-β-D-glucuronidePurity:98%Molecular weight:585.55g/molEzetimibe Phenoxy β-D-Glucuronide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Phase-II metabolite of Ezetimibe, an antihyperlipoproteinemic. A Cholesterol absorption inhibitor.This compound is very hygroscopic. Handle with care.<br>References van Heek, M., at al.: J. Pharmacol. Exp. Ther., 283, 157 (1997), van Heek, M., at al.: Brit. J. Pharmacol., 129, 1748 (2000)<br></p>Formula:C30H29F2NO9Color and Shape:White To Light BrownMolecular weight:585.55Ezetimibe b-D-glucuronide
CAS:<p>Ezetimibe b-D-glucuronide is a glucuronide conjugate of ezetimibe. It can be found in human serum, as well as in the liver and small intestine. Ezetimibe b-D-glucuronide has been shown to inhibit uptake of uridine into Caco2 cells, which may be due to its ability to inhibit the activity of drug transporters such as P-glycoprotein and organic anion transporting polypeptides. This drug also inhibits the production of creatine kinase in the liver and lowers cholesterol levels by inhibiting dietary cholesterol absorption. The drug interactions with statins are still unclear and require further investigation. Ezetimibe b-D-glucuronide is metabolized by glucuronidation in the liver and small intestine.</p>Formula:C30H29F2NO9Purity:Min. 95%Color and Shape:PowderMolecular weight:585.55 g/mol








